Predicting the Outcome of Cytoreductive Surgery for Advanced Ovarian Cancer: A Review
Authors:
- Robert E. BristowRBRobert E. Bristow
- 1 January 2010
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 20, S1-S11
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancerGynecologic Oncology, 2006
- Ovarian cancer in younger vs older women: a population-based analysisBritish Journal of Cancer, 2006
- “Optimal” cytoreduction for advanced epithelial ovarian cancer: A commentaryGynecologic Oncology, 2006
- Ethnic differences in survival among women with ovarian carcinomaCancer, 2002
- Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective StudyGynecologic Oncology, 1998
- Patterns of care for women with ovarian cancer in the United States.Journal of Clinical Oncology, 1997
- Does Debulking Surgery Improve Survival in Biologically Aggressive Ovarian Carcinoma?Gynecologic Oncology, 1997
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989